News Sentiment

ILMN sentiment intelligence

Illumina Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 54 Balanced news tone 59 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Diagnostics & Research Read-through group
Latest close 186.65 Week of 17 Jul 2026
Weighted tone 54/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 59

directly relevant articles

Source quality 5

high-authority source matches

Trend context Trend active

-1.9% over one week, +15.3% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Is Illumina Inc (ILMN) Overvalued After 4.2% Rally? GF Value Say

Market Reaction

Balanced read

64/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction -1.9% Price digesting
Trend fit Trend active 15.3% over four weeks
Fair value 52.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 18
Neutral 35
Negative 6

Relevance

Why the article matched

Direct first
Direct company coverage 59
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Ad-hoc-news.de 7
Market source 7
Stock Titan 7
PR Newswire 5
simplywall.st 5
TradingView 5
MarketWatch 3
GuruFocus 2

Event Lens

What the news is about

Classified themes
Market update 37
Earnings 14
Regulatory and legal 3
Analyst action 3
Guidance 1
Deals and strategy 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-59 of 59
insights.citeline.com Direct company coverage

Roche Launches AXELIOS 1 Sequencer At $750,000, Targeting Illumina’s Market

Roche has launched its new AXELIOS 1 Sequencer, priced at $750,000, directly challenging Illumina's market dominance. The sequencer is capable of generating reads up to 1,500 base pairs, positioning Roche as a significant competitor in the genomics sequencing industry. This move

Tone
Negative 35/100
Event
Market update
Published
29 Jun 2026 07:13
Source
insights.citeline.com
TradingView Direct company coverage

Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh Actuals & Estimates (BMFBOVESPA:I1LM34)

This page provides financial actuals and estimates for Illumina, Inc. Unsponsored Brazilian Depositary Receipt Repr 0.2 Sh (BMFBOVESPA:I1LM34) on TradingView. Users can explore reported financial data and analyst estimates, comparing actual results with average, high, and low est

Tone
Neutral 50/100
Event
Earnings
Published
26 Jun 2026 16:10
Source
TradingView
GuruFocus Direct company coverage

Insider Sell: Scott Davies Sells Shares of Illumina Inc (ILMN)

Scott Davies, Chief Legal Officer of Illumina Inc's subsidiary, sold 615 shares of Illumina Inc (ILMN) on June 25, 2026. This transaction brings his total holdings to 20,953 shares. The stock is currently trading at $180, significantly above its GF Value of $129.16, indicating it

Tone
Neutral 50/100
Event
Market update
Published
26 Jun 2026 04:10
Source
GuruFocus
Stock Titan Direct company coverage

Illumina (NASDAQ: ILMN) legal chief sells 615 shares in open-market trade

Illumina's Chief Legal Officer, Scott M. Davies, sold 615 shares of the company's common stock at $180 per share in an open-market transaction. This sale, totaling $110,700, represents a small portion of his overall direct holdings, which now stand at 20,953 shares. The transacti

Tone
Negative 38/100
Event
Market update
Published
26 Jun 2026 02:10
Source
Stock Titan
Stock Titan Direct company coverage

Illumina (NASDAQ: ILMN) affiliate files Form 144 reporting 98,400-share 10b5-1 sale

An Illumina (NASDAQ: ILMN) affiliate has filed Form 144 to report the proposed sale of 98,400 common shares. The filing details a 10b5-1 sale on May 29, 2026, linked to Performance Stock Units and Restricted Stock Units granted on February 21, 2023. This is a regulatory notice of

Tone
Neutral 50/100
Event
Regulatory and legal
Published
25 Jun 2026 20:09
Source
Stock Titan
Stock Titan Direct company coverage

Frances Arnold sells Illumina shares (ILMN) in multiple May–June 2026 trades

Frances Arnold reported proposed sales of Illumina (ILMN) common stock through a Form 144 filing, detailing multiple dispositions in May–June 2026. These include sales of 3,000 shares on June 2, 2026, for $484,571.70 and 5,000 shares on May 28, 2026, for $780,650.00. The filing a

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 20:09
Source
Stock Titan
AlphaStreet Direct company coverage

Illumina Jumps 7.7% Amid Sector-Wide Rally

Illumina (ILMN) saw its stock surge by 7.7% on Wednesday, closing at $177.66, driven by a broad sector-wide rally in diagnostics and research stocks. This gain was part of a larger trend, with several other life sciences companies also experiencing significant increases. The rall

Tone
Positive 75/100
Event
Market update
Published
25 Jun 2026 11:10
Source
AlphaStreet
Stock Titan Direct company coverage

Illumina (ILMN) director Daniel Skovronsky receives 1,674-share RSU grant

Illumina director Daniel Skovronsky received a grant of 1,674 restricted stock units (RSUs), valued at $164.28 per share, representing his total direct holding after this transaction. The RSUs will vest entirely on the earlier of one year from the grant date or the date immediate

Tone
Neutral 50/100
Event
Market update
Published
24 Jun 2026 22:10
Source
Stock Titan
Market source Direct company coverage

Why Illumina (ILMN) Stock Is Trading Up Today

Illumina's stock (ILMN) surged 6.6% after the company appointed Daniel M. Skovronsky, a high-profile Eli Lilly executive, to its board of directors. Barclays also increased its price target for Illumina to $145 from $122, noting that life science and diagnostic tools are gaining

Tone
Positive 74/100
Event
Analyst action
Published
24 Jun 2026 18:40
Source
Market source